+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Thyroid Cancer Diagnostics Market by Technology (Immunoassay, Immunohistochemistry, Next Generation Sequencing), Sample Type (Blood Sample, Fine Needle Aspiration, Tissue Biopsy), Biomarker Type, Application, End User - Global Forecast 2025-2030- Product Image
Thyroid Cancer Diagnostics Market by Technology (Immunoassay, Immunohistochemistry, Next Generation Sequencing), Sample Type (Blood Sample, Fine Needle Aspiration, Tissue Biopsy), Biomarker Type, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Thyroid Cancer Diagnostics Market by Technology (Immunoassay, Immunohistochemistry, Next Generation Sequencing), Sample Type (Blood Sample, Fine Needle Aspiration, Tissue Biopsy), Biomarker Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533182
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The thyroid cancer diagnostics market is undergoing a transformation as regulatory policies, technology innovation, and shifting clinical demands reshape care strategies worldwide. Stakeholders require timely intelligence to navigate this dynamic environment, where precision, speed, and adaptable solutions define competitive advantage.

Market Snapshot: Thyroid Cancer Diagnostics Market Growth

The global thyroid cancer diagnostics market grew from USD 257.58 million in 2024 to USD 273.14 million in 2025 and is on track to reach USD 360.55 million by 2030. The market expands at a CAGR of 5.76%, reflecting robust demand for advanced assays and molecular platforms as incidence rates and clinical awareness rise globally.

Scope & Segmentation

This report provides comprehensive analysis across the entire thyroid cancer diagnostics value chain, empowering executives to assess risk, identify opportunities, and inform technology investments.

  • Technology Categories: Immunoassay (chemiluminescence immunoassay, ELISA), immunohistochemistry, next generation sequencing (targeted, whole exome, whole genome), and real time PCR (digital PCR, qPCR).
  • Sample Types: Blood collection, fine needle aspiration, and tissue biopsy.
  • Biomarker Types: Epigenetic markers (DNA methylation, miRNA), genetic markers (BRAF, RAS, TERT), and protein markers (calcitonin, thyroglobulin).
  • Clinical Applications: Diagnosis, prognosis, recurrence monitoring, and therapy monitoring.
  • End Users: Academic research institutes, cancer research centers, university laboratories, ambulatory care centers, imaging centers, specialized clinics, diagnostic laboratories (chain, independent), private and public hospitals.
  • Geographic Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific—with detailed breakdowns for major nations and regional clusters.
  • Company Profiles: Analysis includes F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., QIAGEN N.V., Siemens Healthineers AG, Illumina Inc., Hologic, Inc., Danaher Corporation, Sysmex Corporation, and bioMérieux S.A.

Key Takeaways: Strategic Insights for Decision Makers

  • Regulatory changes are streamlining the pathway for in vitro diagnostic approvals, promoting faster market entry while maintaining quality standards.
  • Innovations in molecular technologies—such as next generation sequencing and digital PCR—are improving diagnostic accuracy and enabling greater personalization of thyroid oncology care.
  • The expansion of biomarker catalogs is allowing laboratories to refine risk stratification and tailor monitoring strategies for increasingly diverse patient populations.
  • Collaboration among developers, payers, and regulatory authorities enhances both clinical validation and reimbursement, supporting a more sustainable diagnostic ecosystem.
  • Emerging integration of digital pathology and artificial intelligence is accelerating image analysis and workflow automation across clinical laboratories.
  • Flexible diagnostic portfolios are vital to address diverse regulatory environments and operational requirements across regions.

Tariff Impact: United States 2025 Trade Measures

Recent U.S. tariff measures on imported reagents, instruments, and consumables have increased operational costs and lengthened supply chain timelines for thyroid cancer diagnostics providers. In response, stakeholders are expanding local or regional sourcing partnerships, collaborating with domestic manufacturers, and optimizing supply portfolios to mitigate procurement risks and pricing volatility.

Methodology & Data Sources

This report integrates qualitative interviews with clinical and industry experts, alongside analysis of peer-reviewed publications, regulatory filings, industry reports, and reimbursement guidelines. Quantitative data are validated through triangulation and advisory panel review, ensuring findings are both reliable and actionable.

Thyroid Cancer Diagnostics Market: Why This Report Matters

  • Enables C-level leaders to benchmark product portfolios and technology adoption strategies in a rapidly changing landscape.
  • Supports strategic planning by mapping global and regional trends, including regulatory and supply chain challenges.
  • Delivers targeted recommendations to guide investment in innovation and drive sustainable growth.

Conclusion

The thyroid cancer diagnostics market is poised for continued growth as technological advancements and evolving regulation redefine how providers detect, monitor, and manage disease. Stakeholders who align adaptive strategies with robust market intelligence will be best positioned to capture emerging opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of high-resolution ultrasound elastography for improved thyroid nodule characterization
5.2. Integration of artificial intelligence algorithms in ultrasound imaging to enhance diagnostic accuracy in thyroid cancer
5.3. Growing utilization of molecular gene expression classifiers for precise risk stratification in indeterminate thyroid nodules
5.4. Rising demand for next-generation sequencing panels to identify actionable mutations in advanced thyroid carcinoma
5.5. Emergence of minimally invasive ablation techniques as alternative therapies for low-risk papillary thyroid tumors
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Thyroid Cancer Diagnostics Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.2.1. Chemiluminescence Immunoassay
8.2.2. ELISA
8.3. Immunohistochemistry
8.4. Next Generation Sequencing
8.4.1. Targeted Sequencing
8.4.2. Whole Exome Sequencing
8.4.3. Whole Genome Sequencing
8.5. Real Time PCR
8.5.1. Digital PCR
8.5.2. qPCR
9. Thyroid Cancer Diagnostics Market, by Sample Type
9.1. Introduction
9.2. Blood Sample
9.3. Fine Needle Aspiration
9.4. Tissue Biopsy
10. Thyroid Cancer Diagnostics Market, by Biomarker Type
10.1. Introduction
10.2. Epigenetic Markers
10.2.1. DNA Methylation
10.2.2. miRNA
10.3. Genetic Markers
10.3.1. BRAF
10.3.2. RAS
10.3.3. TERT
10.4. Protein Markers
10.4.1. Calcitonin
10.4.2. Thyroglobulin
11. Thyroid Cancer Diagnostics Market, by Application
11.1. Introduction
11.2. Diagnosis
11.3. Prognosis
11.4. Recurrence Monitoring
11.5. Therapy Monitoring
12. Thyroid Cancer Diagnostics Market, by End User
12.1. Introduction
12.2. Academic Research Institutes
12.2.1. Cancer Research Centers
12.2.2. University Laboratories
12.3. Ambulatory Care Centers
12.3.1. Imaging Centers
12.3.2. Specialized Clinics
12.4. Diagnostic Laboratories
12.4.1. Chain Laboratories
12.4.2. Independent Laboratories
12.5. Hospitals
12.5.1. Private Hospitals
12.5.2. Public Hospitals
13. Americas Thyroid Cancer Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Thyroid Cancer Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Thyroid Cancer Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. QIAGEN N.V.
16.3.5. Siemens Healthineers AG
16.3.6. Illumina Inc.
16.3.7. Hologic, Inc.
16.3.8. Danaher Corporation
16.3.9. Sysmex Corporation
16.3.10. bioMérieux S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. THYROID CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. THYROID CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. THYROID CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. THYROID CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. THYROID CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. THYROID CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. THYROID CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. THYROID CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY MIRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY MIRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BRAF, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BRAF, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TERT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TERT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CALCITONIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CALCITONIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THYROGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THYROGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHAIN LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHAIN LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 183. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 186. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 187. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 188. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 189. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2024 (USD MILLION)
TABLE 190. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2025-2030 (USD MILLION)
TABLE 191. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 194. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 195. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 196. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 197. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 198. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 199. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 200. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 201. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 206. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 207. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 208. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 209. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 210. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 211. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 212. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 216. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 217. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 218. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 219. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2024 (USD MILLION)
TABLE 220. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2025-2030 (USD MILLION)
TABLE 221. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 228. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 229. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 236. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 237. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 240. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 241. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DI

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Illumina Inc.
  • Hologic, Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • bioMérieux S.A.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 273.14 Million
Forecasted Market Value ( USD ) by 2030 $ 360.55 Million
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Papillary Carcinoma, Follicular Carcinoma), Technique (Imaging, Biopsy, Blood Test), End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Papillary Carcinoma, Follicular Carcinoma), Technique (Imaging, Biopsy, Blood Test), End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Thyroid Cancer Diagnostics Market Report 2025 - Product Image

Thyroid Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Thyroid Cancer Drugs Market by Cancer Type (Anaplastic Thyroid Cancer (ATC), Follicular Thyroid Cancer (FTC), Hürthle Cell Carcinoma), Treatment Modality (Chemotherapy, Immunotherapy, Radioiodine Therapy), Drug Type, Mode Of Administration, End User - Global Forecast 2025-2030 - Product Image

Thyroid Cancer Drugs Market by Cancer Type (Anaplastic Thyroid Cancer (ATC), Follicular Thyroid Cancer (FTC), Hürthle Cell Carcinoma), Treatment Modality (Chemotherapy, Immunotherapy, Radioiodine Therapy), Drug Type, Mode Of Administration, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.